Syros Pharmaceuticals Inc. (NASDAQ: SYRS) Stock Information | RedChip

Syros Pharmaceuticals Inc. (NASDAQ: SYRS) Listen to this Section


$1.54
+0.0100 ( +0.65% ) 213.5K

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Market Data


Open


$1.54

Previous close


$1.53

Volume


213.5K

Market cap


$41.56M

Day range


$1.51 - $1.62

52 week range


$1.48 - $8.17

Insider Ownership Transactions

Total Amount Purchased: 850,026.00 | $ 1,309,040.04

Date Type Amount Purchased Purchaser
2024-06-04 Sale -4000.00 AKKARAJU SRINIVAS
2024-06-04 Sale -4000.00 Dunsire Deborah
2024-04-05 Sale -10451.00 Roth David
2024-04-02 Sale -2000.00 Chee Conley
2024-04-02 Sale -2000.00 Haas Jason
2024-04-02 Sale -22500.00 Quirk Gerald E
2024-04-02 Sale -2000.00 Roth David
2024-04-02 Sale -6000.00 Simonian Nancy A
2024-04-02 Sale -2000.00 Stephens Kristin
2023-12-26 Buy 904977.00 AKKARAJU SRINIVAS

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
8-k 8K-related 13 Jun 06, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
10-q Quarterly Reports 79 May 14, 2024
ars Annual reports 1 Apr 23, 2024
def Proxies and info statements 7 Apr 23, 2024
pre Proxies and info statements 7 Apr 12, 2024
4 Insider transactions 1 Apr 05, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.